Shine and darkle the blood vessels: Multiparameter hypersensitive MR angiography for diagnosis of panvascular diseases.

Li, Wenyue; Cheng, Junwei; Liu, Chuang; Zhang, Ni; Lin, Hua; He, Fangfei; Gan, Zhihua; Zhang, Peisen et al. · Sci Adv · 2024

basic_science · Level V

Where this comes from

Abstract

Magnetic resonance angiography (MRA) is pivotal for diagnosing panvascular diseases. However, single-modality MRA falls short in diagnosing diverse vascular abnormalities. Thus, contrast agents combining <i>T</i><sub>1</sub> and <i>T</i><sub>2</sub> effects are sought for multiparameter MRA with clinical promise, yet achieving a balance in <i>T</i><sub>1</sub> and <i>T</i><sub>2</sub> contrast enhancement effects remains a scientific challenge. Herein, we developed a hypersensitive multiparameter MRA strategy using dual-modality NaGdF<sub>4</sub> nanoparticles. Because of the longer tumbling time (τ<sub>R</sub>), NaGdF<sub>4</sub> nanoparticles can improve the longitudinal relaxivity (<i>r</i><sub>1</sub>), brightening vessels in <i>T</i><sub>1</sub>-weighted sequences. Simultaneously, the regular arrangement of Gd<sup>3+</sup> in the crystal induces magnetic anisotropy, creating local static magnetic field heterogeneity and generating negative signals in <i>T</i><sub>2</sub>-weighted sequences. Consequently, the efficacy of NaGdF<sub>4</sub>-enhanced high-resolution multiparameter MRA has been validated in diagnosing ischemic stroke and Alzheimer's disease in rodent models. In addition, the dual-contrast imaging has been realized on swine with a clinical 3.0-T magnetic resonance imaging scanner, highly emphasizing the clinical translation prospect.

Medical subject headings